COVID-19: Shimadzu detection reagent kit, manufacturing and marketing approval: Ampdirect ™
Shimadzu:
On September 8, 2020, “Ampdirect ™ 2019-nCoV Detection Kit” was approved for manufacturing and marketing as an in vitro diagnostic drug.
“2019-nCoV detection kit”:
“Ampdirect ™ 2019-nCoV detection kit” is a reagent kit that detects the new coronavirus (SARS-CoV-2) from biological samples.
“Ampdirect ™ technology”:
Shimadzu has been using “Ampdirect ™ technology” * since 1997.
We have developed a large number of “reagents that enable simple and rapid PCR tests from biological samples without purifying nucleic acids.”
The action of PCR inhibitors such as proteins and polysaccharides contained in biological samples can be suppressed.
Without purifying DNA or RNA
Biological samples can be added directly to the PCR reaction solution
It is a technology called.
Ampdirect ™ is a trademark of Shimadzu Corporation.
2020 | News | Shimadzu